Annual EBITDA
-$126.86 M
-$14.97 M-13.38%
31 December 2023
Summary:
Gritstone bio annual earnings before interest, taxes, depreciation & amortization is currently -$126.86 million, with the most recent change of -$14.97 million (-13.38%) on 31 December 2023. During the last 3 years, it has fallen by -$28.20 million (-28.59%). GRTS annual EBITDA is now -598.70% below its all-time high of -$18.16 million, reached on 31 December 2016.GRTS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$20.49 M
+$16.86 M+45.14%
30 June 2024
Summary:
Gritstone bio quarterly earnings before interest, taxes, depreciation & amortization is currently -$20.49 million, with the most recent change of +$16.86 million (+45.14%) on 30 June 2024. Over the past year, it has increased by +$14.99 million (+42.25%). GRTS quarterly EBITDA is now -315.87% below its all-time high of $9.49 million, reached on 31 March 2021.GRTS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$120.99 M
+$11.88 M+8.94%
30 June 2024
Summary:
Gritstone bio TTM earnings before interest, taxes, depreciation & amortization is currently -$120.99 million, with the most recent change of +$11.88 million (+8.94%) on 30 June 2024. Over the past year, it has increased by +$7.00 million (+5.47%). GRTS TTM EBITDA is now -1241.68% below its all-time high of -$9.02 million, reached on 30 September 2017.GRTS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTS EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -13.4% | +42.3% | +5.5% |
3 y3 years | -28.6% | +22.8% | -85.2% |
5 y5 years | -105.9% | +25.0% | -45.3% |
GRTS EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -84.7% | at low | at high | +45.1% | -85.2% | +8.9% |
5 y | 5 years | -105.9% | at low | -315.9% | +45.1% | -91.2% | +8.9% |
alltime | all time | -598.7% | at low | -315.9% | +45.1% | -1241.7% | +8.9% |
Gritstone Bio EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | -$20.49 M(-45.1%) | -$120.99 M(-8.9%) |
Mar 2024 | - | -$37.35 M(+34.9%) | -$132.87 M(+4.7%) |
Dec 2023 | -$126.86 M(+13.4%) | -$27.68 M(-22.0%) | -$126.86 M(-0.9%) |
Sept 2023 | - | -$35.48 M(+9.6%) | -$128.00 M(+6.4%) |
June 2023 | - | -$32.36 M(+3.3%) | -$120.26 M(+3.8%) |
Mar 2023 | - | -$31.34 M(+8.8%) | -$115.90 M(+3.6%) |
Dec 2022 | -$111.89 M(+62.9%) | -$28.82 M(+3.9%) | -$111.87 M(+0.6%) |
Sept 2022 | - | -$27.74 M(-1.0%) | -$111.22 M(+1.1%) |
June 2022 | - | -$28.01 M(+2.6%) | -$110.01 M(+4.2%) |
Mar 2022 | - | -$27.30 M(-3.1%) | -$105.57 M(+53.5%) |
Dec 2021 | -$68.70 M(-30.4%) | -$28.17 M(+6.2%) | -$68.77 M(+5.2%) |
Sept 2021 | - | -$26.53 M(+12.6%) | -$65.34 M(+3.3%) |
June 2021 | - | -$23.57 M(-348.3%) | -$63.28 M(-1.3%) |
Mar 2021 | - | $9.49 M(-138.4%) | -$64.12 M(-35.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$98.66 M(+5.9%) | -$24.74 M(+1.1%) | -$98.66 M(-2.1%) |
Sept 2020 | - | -$24.47 M(+0.3%) | -$100.79 M(-2.7%) |
June 2020 | - | -$24.41 M(-2.6%) | -$103.63 M(+3.3%) |
Mar 2020 | - | -$25.05 M(-6.8%) | -$100.35 M(+7.7%) |
Dec 2019 | -$93.19 M(+51.2%) | -$26.87 M(-1.6%) | -$93.19 M(+11.9%) |
Sept 2019 | - | -$27.31 M(+29.3%) | -$83.28 M(+13.2%) |
June 2019 | - | -$21.12 M(+18.0%) | -$73.58 M(+9.8%) |
Mar 2019 | - | -$17.89 M(+5.6%) | -$66.99 M(+8.7%) |
Dec 2018 | -$61.62 M(+54.9%) | -$16.95 M(-3.7%) | -$61.62 M(+0.0%) |
Sept 2018 | - | -$17.61 M(+21.2%) | -$61.60 M(+16.2%) |
June 2018 | - | -$14.53 M(+16.0%) | -$53.00 M(+37.8%) |
Mar 2018 | - | -$12.53 M(-26.0%) | -$38.47 M(+48.3%) |
Dec 2017 | -$39.79 M(+119.2%) | -$16.93 M(+87.7%) | -$25.94 M(+187.7%) |
Sept 2017 | - | -$9.02 M | -$9.02 M |
Dec 2016 | -$18.16 M | - | - |
FAQ
- What is Gritstone bio annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Gritstone bio?
- What is Gritstone bio annual EBITDA year-on-year change?
- What is Gritstone bio quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Gritstone bio?
- What is Gritstone bio quarterly EBITDA year-on-year change?
- What is Gritstone bio TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Gritstone bio?
- What is Gritstone bio TTM EBITDA year-on-year change?
What is Gritstone bio annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of GRTS is -$126.86 M
What is the all time high annual EBITDA for Gritstone bio?
Gritstone bio all-time high annual earnings before interest, taxes, depreciation & amortization is -$18.16 M
What is Gritstone bio annual EBITDA year-on-year change?
Over the past year, GRTS annual earnings before interest, taxes, depreciation & amortization has changed by -$14.97 M (-13.38%)
What is Gritstone bio quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of GRTS is -$20.49 M
What is the all time high quarterly EBITDA for Gritstone bio?
Gritstone bio all-time high quarterly earnings before interest, taxes, depreciation & amortization is $9.49 M
What is Gritstone bio quarterly EBITDA year-on-year change?
Over the past year, GRTS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$14.99 M (+42.25%)
What is Gritstone bio TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of GRTS is -$120.99 M
What is the all time high TTM EBITDA for Gritstone bio?
Gritstone bio all-time high TTM earnings before interest, taxes, depreciation & amortization is -$9.02 M
What is Gritstone bio TTM EBITDA year-on-year change?
Over the past year, GRTS TTM earnings before interest, taxes, depreciation & amortization has changed by +$7.00 M (+5.47%)